---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-005092"
form_type: "8-K"
ticker: "RKDA"
cik: "0001469443"
company_name: "Arcadia Biosciences, Inc."
filed_at: "2023-02-28T23:59:59+00:00"
generated_at: "2026-06-18T21:49:43.267769+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Arcadia Biosciences implements 1-for-40 reverse stock split effective March 1, 2023

## Summary
- Reverse stock split of common stock at 1:40 ratio, effective 12:01 a.m. ET on March 1, 2023.
- No fractional shares; odd shares rounded up to the next whole number.
- Authorized shares remain 150,000,000; par value unchanged at $0.001 per share.
- Stockholders approved split range (1:10 to 1:40) at Feb 15, 2023 special meeting; board selected 1:40.

## SEC filing metadata
- accession: 0000950170-23-005092
- form_type: 8-K
- ticker: RKDA
- cik: 0001469443
- company_name: Arcadia Biosciences, Inc.
- filed_at: 2023-02-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1469443/000095017023005092/0000950170-23-005092-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1469443/000095017023005092/rkda-20230227.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-005092
- JSON: https://secwatch.observer/filing/0000950170-23-005092.json
- Plain text: https://secwatch.observer/filing/0000950170-23-005092.txt

## Key facts
- Governance Changes
  Arcadia Biosciences, Inc.: Approved and filed a Certificate of Amendment to effect a 1-for-40 reverse stock split of common stock (effective 2023-03-01).
  - Change: charter amendment
  - Effective: 2023-03-01
  source text: On February 27, 2023, Arcadia Biosciences, Inc. (the “Company”) filed a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of Delaware to effect a 1-for-40 reverse stock split of the outstanding shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), effective as of 12:01 a.m. (Delaware time) on March 1, 2023 (the “Reverse Stock Split”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1469443/000095017023005092/0000950170-23-005092-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.